Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(9)
Published: Sept. 12, 2024
Abstract
Extracellular
vesicles
(EVs)
have
emerged
as
key
players
in
intercellular
communication,
facilitating
the
transfer
of
crucial
cargo
between
cells.
Liquid
biopsy,
particularly
through
isolation
EVs,
has
unveiled
a
rich
source
potential
biomarkers
for
health
and
disease,
encompassing
proteins
nucleic
acids.
A
milestone
this
exploration
occurred
decade
ago
with
identification
extracellular
vesicle-associated
DNA
(EV-DNA)
bloodstream
patient
diagnosed
pancreatic
cancer.
Subsequent
years
witnessed
substantial
advancements,
deepening
our
insights
into
molecular
intricacies
EV-DNA
emission,
detection,
analysis.
Understanding
complexities
surrounding
release
addressing
challenges
inherent
research
are
pivotal
steps
toward
enhancing
liquid
biopsy-based
strategies.
These
strategies,
detection
monitoring
various
pathological
conditions,
cancer,
rely
on
comprehensive
understanding
why
how
is
released.
In
review,
we
aim
to
provide
thorough
summary
decade’s
worth
EV-DNA.
We
will
delve
diverse
mechanisms
its
biomarker,
functional
capabilities,
discordant
findings
field,
hurdles
hindering
clinical
application.
Looking
ahead
next
decade,
envision
that
advancements
EV
techniques,
coupled
improved
standardization
data
sharing,
catalyze
development
novel
strategies
exploiting
both
therapeutic
targets.
Cell Biology and Toxicology,
Journal Year:
2025,
Volume and Issue:
41(1)
Published: Feb. 24, 2025
Human
umbilical
cord
mesenchymal
stem
cell-derived
small
extracellular
vesicles
(hucMSC-sEV)
have
recently
garnered
attention
as
a
potential
therapeutic
approach
for
kidney
diseases
with
anti-inflammatory
effects.
Infiltrated
macrophages
play
an
important
role
in
facilitating
tissue
regeneration.
However,
the
intricate
regulatory
effects
of
hucMSC-sEV
on
during
cisplatin-induced
acute
injury
(AKI)
remain
unknown.
In
this
study,
we
uncovered
that
exhibited
potent
anti-inflammation
and
effectively
inhibited
polarization
M1
phenotype
macrophages.
Mechanically,
miRNA
sequencing
analysis
qRT-PCR
indicated
novel
miRNA,
named
miR-13896,
was
enriched
hucMSC-sEV.
When
transfected
miR-13896
mimic,
displayed
M2
elevated
levels
Arg1
IL-10,
while
inhibitor
promoted
phenotype.
Furthermore,
firstly
established
repressed
Tradd
expression
by
targeting
its
3'
untranslated
region
subsequently
NF-κB
signaling
pathway
Additionally,
to
improve
effects,
were
engineered
through
electroporation,
which
resulted
promoting
macrophages,
inhibiting
inflammatory
factors,
enhancing
repair.
Conclusively,
our
findings
provide
insights
into
mechanisms
underlying
AKI,
also
highlighting
electroporation
promising
strategy
treating
AKI.
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(9)
Published: Feb. 26, 2025
Naturally
occurring
extracellular
vesicles
(EVs)
and
synthetic
nanoparticles
like
liposomes
have
revolutionized
precision
diagnostics
medicine.
EVs
excel
in
biocompatibility
cell
targeting,
while
offer
enhanced
drug
loading
capacity
scalability.
The
clinical
translation
of
is
hindered
by
challenges
including
low
yield
heterogeneity,
whereas
face
rapid
immune
clearance
limited
targeting
efficiency.
To
bridge
these
gaps,
biomimetic
(SVs)
emerged
as
innovative
platforms,
combining
the
advantageous
properties
liposomes.
This
review
emphasizes
critical
aspects
EV
biology,
such
mechanisms
EV-cell
interaction
source-dependent
functionalities
modulation,
tissue
regeneration,
informing
SV
engineering.
We
reviewed
a
broad
array
SVs,
with
focus
on
lipid
bilayered
functionalized
proteins.
These
include
cell-derived
nanovesicles,
protein-functionalized
liposomes,
hybrid
vesicles.
By
addressing
current
highlighting
opportunities,
this
aims
to
advance
SVs
for
transformative
biomedical
applications.
Pharmacological Reviews,
Journal Year:
2023,
Volume and Issue:
76(2), P. 199 - 227
Published: Dec. 19, 2023
Abstract
Extracellular
vesicles
(EVs)
have
emerged
as
an
attractive
liquid
biopsy
approach
in
the
diagnosis
and
prognosis
of
multiple
diseases
disorders.
The
feasibility
enriching
specific
subpopulations
EVs
from
biofluids
based
on
their
unique
surface
markers
has
opened
novel
opportunities
to
gain
molecular
insight
various
tissues
organs,
including
brain.
Over
past
decade,
bodily
fluids
been
extensively
studied
for
biomarkers
associated
with
neurological
disorders,
such
Alzheimer9s
disease,
Parkinson9s
schizophrenia,
bipolar
disorder,
major
depressive
substance
use
human
immunodeficiency
virus–associated
neurocognitive
cancer/treatment-induced
neurodegeneration.
These
studies
focused
isolation
cargo
characterization
either
total
or
brain
cells,
neuron-,
astrocyte-,
microglia-,
oligodendrocyte-,
pericyte-,
endothelial-derived
achieve
early
predict
treatment
intervention
outcomes.
findings
these
demonstrated
that
could
serve
a
repetitive
less
invasive
source
valuable
information
supplementing
existing
costly
neuroimaging
techniques
relatively
measures,
like
lumbar
puncture.
However,
initial
excitement
surrounding
blood-based
brain-related
tempered
by
challenges,
lack
central
nervous
system
specificity
EV
markers,
lengthy
protocols,
absence
standardized
procedures
biological
sample
collection,
isolation,
characterization.
Nevertheless,
rapid
advancements
field,
supported
improved
methods
sensitive
assays
characterization,
cell–derived
continue
offer
unparallel
significant
translational
implications
Significance
Statement
present
Characterizing
holds
potential
yield
information,
thereby
significantly
impacting
development
This
paper
reviewed
methodology
employed
isolate
extracellular
derived
cells
biofluids,
utility
enhancing
understanding
neurodegeneration,
challenges
this
research
field.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Oct. 28, 2023
Abstract
Exosomes
are
secreted
to
the
extracellular
milieu
when
multivesicular
endosomes
(MVEs)
dock
and
fuse
with
plasma
membrane.
However,
MVEs
also
known
lysosomes
for
degradation.
How
directed
membrane
exosome
secretion
rather
than
is
unclear.
Here
we
report
that
a
conversion
of
phosphatidylinositol-3-phosphate
(PI(3)P)
phosphatidylinositol-4-phosphate
(PI(4)P)
catalyzed
sequentially
by
Myotubularin
1
(MTM1)
phosphatidylinositol
4-kinase
type
IIα
(PI4KIIα)
on
surface
mediates
recruitment
exocyst
complex.
The
then
targets
secretion.
We
further
demonstrate
disrupting
PI(4)P
generation
or
function
blocked
exosomal
Programmed
death-ligand
(PD-L1),
key
immune
checkpoint
protein
in
tumor
cells,
led
its
accumulation
lysosomes.
Together,
our
study
suggests
PI(3)P
direct
exocytic
trafficking
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: May 24, 2023
Abstract
Extracellular
vesicles
(EVs),
a
cluster
of
cell-secreted
lipid
bilayer
nanoscale
particles,
universally
exist
in
body
fluids,
as
well
cell
and
tissue
culture
supernatants.
Over
the
past
years,
increasing
attention
have
been
paid
to
important
role
EVs
effective
intercellular
communicators
fibrotic
diseases.
Notably,
EV
cargos,
including
proteins,
lipids,
nucleic
acids,
metabolites,
are
reported
be
disease-specific
can
even
contribute
fibrosis
pathology.
Thus,
considered
biomarkers
for
disease
diagnosis
prognosis.
Emerging
evidence
shows
that
derived
from
stem/progenitor
cells
great
prospects
cell-free
therapy
various
preclinical
models
diseases
engineered
improve
targeting
effectiveness
their
treatment.
In
this
review,
we
will
focus
on
biological
functions
mechanisms
diseases,
potential
novel
therapeutic
strategies.